Skip to content
Stop using now Drug recall · FDA · Published November 18, 2013

Baxter Recalls Nitroglycerin Injection Due to Particulate Matter

Baxter Healthcare Corp. recalls 50 mg Nitroglycerin in 5% Dextrose Injection due to silicone and EPDM rubber particulates found in vials.

🇺🇸 FDA recall #D-1057-2014DrugBaxter Healthcare Corp. ›
Take action

Contact the company

Recalling firmBaxter Healthcare Corp.1 Baxter Pkwy · Deerfield, IL 60015-4625
✎ GovInfoNow plain-language explainer

Baxter Healthcare Corp. is recalling 49,932 glass containers of 50 mg Nitroglycerin in 5% Dextrose Injection (200 mcg/mL). The recall was issued because particulate matter, identified as silicone rubber and EPDM rubber from the vial stopper, was found in one vial. This contamination poses a risk to patients receiving the medication. Read more at govinfonow.com/recall/46403-baxter-healthcare-corp-recalls-50-mg-nitroglycerin-in-5-dextrose.

Source Summary by GovInfoNow · govinfonow.com/recall/46403-baxter-healthcare-corp-recalls-50-mg-nitroglycerin-in-5-dextrose · Updated October 13, 2026 · FDA enforcement record: FDA #D-1057-2014

Cite this page

“Baxter Recalls Nitroglycerin Injection Due to Particulate Matter.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46403-baxter-healthcare-corp-recalls-50-mg-nitroglycerin-in-5-dextrose. Based on FDA recall #D-1057-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1057-2014%22&limit=1).

The FDA announced on Nov. 18, 2013, that Baxter Healthcare Corp. voluntarily recalled 50 mg Nitroglycerin in 5% Dextrose Injection due to the presence of particulate matter identified as silicone rubber and EPDM rubber from vial stoppers. The agency issued recall number D-1057-2014 for the Class I recall.

How to tell if you have it

  • Brand: Baxter Healthcare Corp.
  • Product: Nitroglycerin Injection
  • NDC: 0338-1049-02
  • Lot code: G105197
  • Expiration date: 02/14
  • Quantity: 49,932 glass containers

The hazard

The recall addresses the presence of particulate matter in one vial, which was identified as silicone rubber and EPDM rubber from the vial stopper. The FDA classified this as a Class I recall.

Context

GovInfoNow's records show Baxter Healthcare Corp. has 34 other recalls on record since Sept. 21, 2012. Other recent recalls of similar products include Baxter Amia Dialysis Set Recall (Sept. 1, 2017), Baxter Recalls Brevibloc Injection Due to Discoloration (April 12, 2016), and Baxter Recalls Sodium Chloride Irrigation Due to Insect Contamination (Feb. 5, 2016).

How to tell if you have this one

Check for 50 mg Nitroglycerin in 5% Dextrose Injection (200 mcg/mL) in 250 mL glass containers. Look for NDC 0338-1049-02 and lot number G105197 with an expiration date of 02/14.

  • Brand
    Baxter Healthcare Corp.
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using the Product

    Do not administer this medication if you have it in your possession.

  2. Contact Your Provider

    If you are a healthcare provider or patient, contact Baxter Healthcare Corp. for further instructions on returning or disposing of the product.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide, Saudi Arabia and Colombia” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 10 months after the firm started it.

1. Firm started the recall: Nov 18, 201312. FDA classified it Class I: Jan 31, 201423. Published in FDA’s Enforcement Report: Feb 12, 201434. FDA terminated the recall: Sep 15, 2014420132014
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1057-2014 (November 18, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1057-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA